The Illinois denial segment captures a specific configuration: the member holds a fully-insured DOI-licensed plan issued in Illinois (Aetna, Blue Cross and Blue Shield of Illinois — Health Care Service Corporation / HCSC, Cigna, Humana, UnitedHealthcare), or an Illinois Medicaid managed-care plan run through the Department of Healthcare and Family Services (HFS), or a self-funded employer ERISA group plan. The denial reason will track the carrier’s internal reason code (medical necessity, prior authorization, step therapy, formulary exclusion, out-of-network), but the appeal frameworks that attach are Illinois-specific. The Illinois Department of Insurance (DOI) regulates carriers under the Illinois Insurance Code at 215 ILCS 5/143 et seq., the Illinois Utilization Review Act at 215 ILCS 97 imposes utilization-review program standards, and 50 Ill. Adm. Code 4525 establishes the external-review pathway — 30-day filing window from the Final Internal Adverse Determination, with the IRO list maintained by the DOI. The DOI Consumer Division line at 1-877-527-9431 and insurance.illinois.gov are the front door for Illinois members.
DOI-regulated carriers operating in Illinois — Aetna, BCBS Illinois (HCSC), Cigna, Humana, UnitedHealthcare’s fully-insured IL products — are subject to the Illinois UR Act at 215 ILCS 97 and 50 Ill. Adm. Code 4525: a 30-day internal appeal under § 143 (insurance.illinois.gov), a 30-day external review (IRO) deadline from the Final Internal Adverse Determination, and the 24-hour expedited external review under the Illinois UR Act for ongoing-care cases. The 215 ILCS 125/5-6 psychiatric and substance-use step-therapy carve-out is an Illinois-specific ground to challenge the carrier’s fail-first protocol on those prescription types — and the appeal letter cites it directly where the denial involves a psychiatric or substance-use prescription. The DOI complaint pathway runs parallel to the federal 4-month ACA external-review window at 45 C.F.R. § 147.136(d) for ACA marketplace plans operating in Illinois.
Self-funded ERISA plans — the typical larger-employer group plan where the employer pays the claims rather than buying insurance from a carrier — fall outside DOI jurisdiction and outside 50 Ill. Adm. Code 4525, and run through the federal ERISA § 503 claims-procedure rule at 29 C.F.R. § 2560.503-1, with the 4-month federal external-review channel at 29 C.F.R. § 2590.715-2719 for non-grandfathered plans and ERISA § 502(a) civil action at 29 U.S.C. § 1132(a)(1)(B) as the post-exhaustion remedy. IL UR laws (215 ILCS 97; 50 Ill. Adm. Code 4525) still apply to procedural aspects the federal rule does not preempt — clinical-criteria disclosure, peer-reviewer escalation, the UR agent standards — but the appeals timeline and the right-to-file-a-civil-action follow fully from 29 C.F.R. § 2560.503-1 and ERISA § 502(a). A well-built Illinois appeal letter cites both: the controlling IL statute (215 ILCS 97 / 50 Ill. Adm. Code 4525 for DOI-regulated plans, plus 215 ILCS 125/5-6 for psychiatric / substance-use step therapy) or the federal preemption fallback (29 C.F.R. § 2560.503-1 for self-funded ERISA), and the right federal framework underneath.